These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. Karussis D J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923 [TBL] [Abstract][Full Text] [Related]
26. The onset location of multiple sclerosis predicts the location of subsequent relapses. Mowry EM; Deen S; Malikova I; Pelletier J; Bacchetti P; Waubant E J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):400-3. PubMed ID: 19066192 [TBL] [Abstract][Full Text] [Related]
27. Multiple Sclerosis in Keralite siblings after migration to the Middle East: a report of familial Multiple Sclerosis from India. Narayan SK; Kumar S; Prabhakar P; Elangovan S; Baumann N; Verma IC J Neurol Sci; 2007 Sep; 260(1-2):244-8. PubMed ID: 17588606 [TBL] [Abstract][Full Text] [Related]
28. Pediatric multiple sclerosis: from clinical basis to imaging spectrum and differential diagnosis. Padilha IG; Fonseca APA; Pettengill ALM; Fragoso DC; Pacheco FT; Nunes RH; Maia ACM; da Rocha AJ Pediatr Radiol; 2020 May; 50(6):776-792. PubMed ID: 31925460 [TBL] [Abstract][Full Text] [Related]
29. Characterisation of the spectrum of demyelinating disease in Western Australia. Wu JS; Zhang MN; Carroll WM; Kermode AG J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1022-6. PubMed ID: 18356258 [TBL] [Abstract][Full Text] [Related]
30. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Keegan BM; Kaufmann TJ; Weinshenker BG; Kantarci OH; Schmalstieg WF; Paz Soldan MM; Flanagan EP Mult Scler; 2018 Oct; 24(11):1445-1452. PubMed ID: 30047830 [TBL] [Abstract][Full Text] [Related]
31. Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis? Pietroboni AM; Arighi A; De Riz MA; Ghezzi L; Calvi A; Avignone S; Scola E; Galimberti D; Triulzi F; Scarpini E Neurol Sci; 2015 Dec; 36(12):2277-80. PubMed ID: 26109007 [TBL] [Abstract][Full Text] [Related]
32. Neuropsychological outcomes of pediatric demyelinating diseases: a review. Tan A; Hague C; Greenberg BM; Harder L Child Neuropsychol; 2018 Jul; 24(5):575-597. PubMed ID: 28637379 [TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. Mirmosayyeb O; Brand S; Barzegar M; Afshari-Safavi A; Nehzat N; Shaygannejad V; Sadeghi Bahmani D J Clin Med; 2020 May; 9(5):. PubMed ID: 32370288 [TBL] [Abstract][Full Text] [Related]
34. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Burton JM; O'Connor PW; Hohol M; Beyene J Cochrane Database Syst Rev; 2009 Jul; (3):CD006921. PubMed ID: 19588409 [TBL] [Abstract][Full Text] [Related]